rimactan 150 mg kapsler, hårde
2care4 aps - rifampicin - kapsler, hårde - 150 mg
rimstar 150+75+400+275 mg filmovertrukne tabletter
orifarm a/s - ethambutolhydrochlorid, isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150+75+400+275 mg
suxamethonium chloride "aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte
laboratoire aguettant - suxamethoniumchlorid (vandfrit) - injektionsvæske, opløsning i fyldt injektionssprøjte - 10 mg/ml
rifampar 150+75+400+275 mg filmovertrukne tabletter
paranova danmark a/s - ethambutolhydrochlorid, isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150+75+400+275 mg
sorafenib "mylan" 200 mg filmovertrukne tabletter
mylan ab - sorafenibtosylat - filmovertrukne tabletter - 200 mg
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinale stromale tumorer - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.
lapatinib "newbury" 250 mg filmovertrukne tabletter
newbury pharmaceuticals ab - lapatinibditosylatmonohydrat - filmovertrukne tabletter - 250 mg